EVOFEM BIOSCIENCES, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $142.1M | $42.5M | $7.7M |
| FY2022 | $97.0M | $25.2M | $2.8M |
| FY2023 | $72.5M | $10.6M | $580.0K |
| FY2024 | $90.3M | $23.8M | $741.0K |
| FY2025 | $89.7M | $20.3M | $578.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $142.1M | $42.5M | $7.7M |
| FY2022 | $97.0M | $25.2M | $2.8M |
| FY2023 | $72.5M | $10.6M | $580.0K |
| FY2024 | $90.3M | $23.8M | $741.0K |
| FY2025 | $89.7M | $20.3M | $578.0K |